Molecular mechanism underlying the renoprotective action of vitamin D

Circulation Journal

Volumn 78, Issue 3, 2014, Pages 599-600

  Nakayama, Yosuke ^a   Ueda, Seiji ^a   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; DNA; FIBROBLAST GROWTH FACTOR 23; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; NEPHRIN; RENIN; TRANSCRIPTION FACTOR NRF2; VITAMIN D; VITAMIN D BINDING PROTEIN; CALCITRIOL;

ALBUMINURIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; OXIDATIVE STRESS; PODOCYTE; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; BLOOD; KIDNEY DISEASE; MALE;

CALCITRIOL; HUMANS; KIDNEY DISEASES; MALE; VITAMIN D DEFICIENCY;

EID: 84894506318     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0058     Document Type: Editorial

References (15)

1. Dan K, Miyoshi T, Ueeda M, Ohtsuka H, Ugawa S, Ohnishi N, et al. Impact of chronic kidney disease on left main coronary artery disease and prognosis in Japanese patients. Circ J 2012; 76: 2266-2272.
2. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89/90: 387-392.
3. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291: E315-E322, doi:10.1152/ajpendo.00590.2005.
4. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-515.
5. Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease. Exp Cell Res 2012; 318: 1040-1048.
6. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408.
7. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38.
8. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95.
9. Izumaru K, Ninomiya T, Nagata M, Usui T, Yoshida D, Yonemoto K, et al. Serum 1,25-dihydroxyvitamin D and the development of kidney dysfunction in a Japanese community: The Hisayama Study. Circ J 2014; 78: 732-737.
10. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007; 50: 69-77.
11. Menzel S, Moeller MJ. Role of the podocyte in proteinuria. Pediatr Nephrol 2011; 26: 1775-1780.
12. Deb DK, Wang Y, Zhang Z, Nie H, Huang X, Yuan Z, et al. Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression. J Biol Chem 2011; 286: 32011-32017.
13. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the rennin gene promoter. J Biol Chem 2007; 282: 29821-29830.
14. Tan X, Wen X, Liu Y. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 2008; 19: 1741-1752.
15. Nakai K, Fujii H, Kono K, Goto S, Kitazawa R, Kitazawa S, et al. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am J Hypertens 2013 September 11, doi:10.1093/ajh/hpt160 [E-pub ahead of print].